Pier Paolo Pandolfi
Overview
Explore the profile of Pier Paolo Pandolfi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
387
Citations
42032
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sax S, Centomo M, Centofanti F, Rizzacasa B, Cox S, Cox C, et al.
Int J Mol Sci
. 2024 Nov;
25(21).
PMID: 39519210
Senescence and apoptosis are two fundamental cellular processes that play crucial roles in various physiological and pathological conditions. Senescence refers to the irreversible growth arrest that cells undergo in response...
2.
Poliseno L, Lanza M, Pandolfi P
Cell Res
. 2024 Jul;
34(9):609-629.
PMID: 39054345
The advent of high-throughput sequencing uncovered that our genome is pervasively transcribed into RNAs that are seemingly not translated into proteins. It was also found that non-coding RNA transcripts outnumber...
3.
Monteleone E, Corrieri P, Provero P, Viavattene D, Pulvirenti L, Raggi L, et al.
Brief Funct Genomics
. 2023 Oct;
23(5):651-662.
PMID: 37801430
Embryonic stem cells (ESCs) preserve the unique ability to differentiate into any somatic cell lineage while maintaining their self-renewal potential, relying on a complex interplay of extracellular signals regulating the...
4.
Panella R, Petri A, Desai B, Fagoonee S, Cotton C, Nguyen P, et al.
Int J Mol Sci
. 2023 Aug;
24(16).
PMID: 37629051
Obesity is a growing public health problem associated with increased risk of type 2 diabetes, cardiovascular disease, nonalcoholic fatty liver disease (NAFLD) and cancer. Here, we identify microRNA-22 (miR-22) as...
5.
Garcia-Vilchez R, Anazco-Guenkova A, Dietmann S, Lopez J, Moron-Calvente V, DAmbrosi S, et al.
Mol Cancer
. 2023 Jul;
22(1):119.
PMID: 37516825
Newly growing evidence highlights the essential role that epitranscriptomic marks play in the development of many cancers; however, little is known about the role and implications of altered epitranscriptome deposition...
6.
Centofanti F, Buono A, Verboni M, Tomino C, Lucarini S, Duranti A, et al.
Pharmaceuticals (Basel)
. 2023 Jun;
16(2).
PMID: 37259386
Indole-3-carbinol (I3C) is a natural product contained in vegetables belonging to the family and has been studied in recent decades for its biological and pharmacological properties. Herein, we will analyze:...
7.
Panella R, Cotton C, Maymi V, Best S, Berry K, Lee S, et al.
Biomedicines
. 2023 May;
11(5).
PMID: 37239141
microRNA-22 (miR-22) is an oncogenic miRNA whose up-regulation promotes epithelial-mesenchymal transition (EMT), tumor invasion, and metastasis in hormone-responsive breast cancer. Here we show that miR-22 plays a key role in...
8.
Yehia L, Centomo M, Pandolfi P, Eng C
J Thorac Oncol
. 2023 Feb;
18(3):260-261.
PMID: 36842808
No abstract available.
9.
Orso F, Virga F, Dettori D, Dalmasso A, Paradzik M, Savino A, et al.
J Exp Clin Cancer Res
. 2023 Jan;
42(1):20.
PMID: 36639824
Background: Tumor progression is based on a close interaction between cancer cells and Tumor MicroEnvironment (TME). Here, we focus on the role that Cancer Associated Fibroblasts (CAFs), Mesenchymal Stem Cells...
10.
Centomo M, Vitiello M, Poliseno L, Pandolfi P
Cancers (Basel)
. 2022 Dec;
14(24).
PMID: 36551740
MiR-22 was first identified as a proto-oncogenic microRNA (miRNA) due to its ability to post-transcriptionally suppress the expression of the potent PTEN (Phosphatase And Tensin Homolog) tumor suppressor gene. miR-22...